Tridacaine Xl Patch
Product Images NDC 73352-845

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Xl (NDC 73352-845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacainexl 01)

FDA Label Image

Figure 1 (Tridacainexl 02)

FDA Label Image

Principal Display Panel (30 Patch Box Label)

Principal Display Panel (30 Patch Box Label)
This is a description of Tridacaine X Lidocaine Patch 5%, a topical pain relief product. Each adhesive patch contains 700 mg of Lidocaine USP (50 mg per gram adhesive) in an aqueous base. The patches also contain various inactive components such as polyethylene terephthalate (PET) backing, glycerin, propylene glycol, polyvinyl alcohol, and preservatives. The usual dosage and prescribing information can be found in the accompanying product information. This product is distributed by Thiuent Pharma and should be stored at 20° to 25°C. A warning is given to keep both used and unused patches out of reach of children, pets, and others. Each package contains 30 patches, with each patch individually wrapped.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.